Mon, November 13, 2023
Sun, November 12, 2023
Fri, November 10, 2023
Thu, November 9, 2023

Andrew Fein Maintained (AMLX) at Strong Buy with Decreased Target to $42 on, Nov 10th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-42-on-nov-10th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Andrew Fein of HC Wainwright & Co., Maintained "Amylyx Pharmaceuticals, Inc." (AMLX) at Strong Buy with Decreased Target from $50 to $42 on, Nov 10th, 2023.

Andrew, nor any peers, have made any analyst calls on AMLX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Publication Contributing Sources